NCT04318691

Brief Summary

The study aims to evaluate the prognostic value of alveolar and blood NETosis in patients under mechanical ventilation and treated for an acute low-respiratory tract infection. The main outcome is the occurrence of an acute respiratory distress syndrome (ARDS) according to the Berlin definition.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jun 2022

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 20, 2020

Completed
4 days until next milestone

First Posted

Study publicly available on registry

March 24, 2020

Completed
2.2 years until next milestone

Study Start

First participant enrolled

June 7, 2022

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 3, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 3, 2023

Completed
Last Updated

March 16, 2023

Status Verified

March 1, 2023

Enrollment Period

7 months

First QC Date

March 20, 2020

Last Update Submit

March 15, 2023

Conditions

Keywords

acute respiratory distress syndromeadult ICUneutrophil extracellular traps (NETs)Netosisneutrophilsmechanical ventilationpneumonia

Outcome Measures

Primary Outcomes (1)

  • Acute respiratory distress syndrome occurrence

    Acute respiratory distress syndrome occurrence according to the Berlin definition within the first 7 days after ICU admission

    at day-7

Secondary Outcomes (6)

  • Mortality

    At day-28

  • Duration of mechanical ventilation

    At day-28

  • IGSII score

    At admission to ICU

  • SOFA score

    At admission to ICU

  • Hemodynamic failure

    At day-28

  • +1 more secondary outcomes

Study Arms (3)

acute respiratory failure group

60 patients under mechanical ventilation admitted to the intensive care unit for acute respiratory failure

Biological: Blood samplingProcedure: Bronchoalveolar lavage

vascular surgery control group

10 control patients admitted to the ICU after a planned vascular surgery

Biological: Blood sampling

Healthy volunteers group

10 healthy subjects.

Biological: Blood sampling

Interventions

Blood samplingBIOLOGICAL

Blood sampling at baseline and at day-3 (10 ml, EDTA tube), test of NETs.

Healthy volunteers groupacute respiratory failure groupvascular surgery control group

Bronchoalveolar lavage at admission to the ICU with analysis of cytological, bacteriological, viral and anatomopathological, and test of NETs.

acute respiratory failure group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

* Adult ICU patients under mechanical ventilation with suspected lower-respiratory tract infection; * Adult ICU patients followed vascular surgical intervention; * Healthy Volunteers.

You may qualify if:

  • A/ For all subjets:
  • Be \>/= 18 years of age on day of signing informed consent;
  • Affiliated to the french social security - welfare system in France.
  • admitted to the ICU for acute respiratory failure requiring mechanical ventilation within the first 24 hours after admission and suspected to suffer from an infectious pneumonia, according to the following criteria:
  • recent fever;
  • acute respiratory failure signs (dyspnea, polypnea \> 30 cycles/min, hypoxemia PaO2\<65 mmHg);
  • pulmonary focal signs of auscultation;
  • evocative signs in chest radiography or chest TDM.
  • \- admitted to the ICU for post-operative management of vascular surgery.

You may not qualify if:

  • A/ For all subjets:
  • pregnancy,
  • nosocomial pneumonia,
  • no social health insurance,
  • neutropenia of any cause;
  • patient refusal.
  • \- no mechanical ventilation within the first 24 hours after admission to the ICU.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Service de médecine intensive réanimation, Hôpital Ambroise Paré, APHP

Boulogne-Billancourt, 92100, France

Location

MeSH Terms

Conditions

Respiratory Tract InfectionsRespiratory Distress SyndromePneumonia

Interventions

Blood Specimen CollectionBronchoalveolar Lavage

Condition Hierarchy (Ancestors)

InfectionsRespiratory Tract DiseasesLung DiseasesRespiration Disorders

Intervention Hierarchy (Ancestors)

Specimen HandlingClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisPuncturesSurgical Procedures, OperativeInvestigative TechniquesTherapeutic Irrigation

Study Officials

  • Edouard JULLIEN, MD

    Service de médecine intensive réanimation, Hôpital Ambroise Paré, APHP

    PRINCIPAL INVESTIGATOR
  • Guillaume Geri, MD, PhD

    Service de médecine intensive réanimation, Hôpital Ambroise Paré, APHP

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 20, 2020

First Posted

March 24, 2020

Study Start

June 7, 2022

Primary Completion

January 3, 2023

Study Completion

January 3, 2023

Last Updated

March 16, 2023

Record last verified: 2023-03

Data Sharing

IPD Sharing
Will not share

Locations